Suppr超能文献

凝血调节蛋白的糖胺聚糖成分在其加速凝血酶使单链尿激酶型纤溶酶原激活剂失活过程中的作用。

Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin.

作者信息

de Munk G A, Parkinson J F, Groeneveld E, Bang N U, Rijken D C

机构信息

IVVO-TNO Gaubius Laboratory, Leiden, The Netherlands.

出版信息

Biochem J. 1993 Mar 15;290 ( Pt 3)(Pt 3):655-9. doi: 10.1042/bj2900655.

Abstract

Thrombomodulin (TM), a membrane proteoglycan on endothelial cells, binds thrombin in a 1:1 complex, accelerates the protein C activation by thrombin, promotes the thrombin inactivation by antithrombin III and inhibits the procoagulant properties of thrombin. The inactivation of single-chain urokinase-type plasminogen activator (scu-PA) by thrombin is accelerated about 70-fold by TM [De Munk, Groeneveld and Rijken (1991) J. Clin. Invest. 88, 1680-1684]. The present study investigates the role of the O-linked glycosaminoglycan moiety of TM in the latter reaction. In the presence of an excess of a fully-glycosylated soluble recombinant human TM mutant (high-Mr rec-TM), 0.11 nM thrombin inactivated 50% of 4.4 nM scu-PA in 45 min at 37 degrees C. In the presence of a soluble recombinant TM mutant lacking the glycosaminoglycans (low-Mr rec-TM), 1.9 nM thrombin was needed to inactivate 50% scu-PA, as compared with 4.7 nM thrombin in the absence of TM. Using the scu-PA inactivation assay the dissociation constant for the thrombin-TM interaction was found to be 0.4 nM for high-Mr rec-TM and 14 nM for low-Mr rec-TM. Treatment of high-Mr rec-TM with chondroitinase ABC to digest the glycosaminoglycans decreased the accelerating effect to the level of low-Mr rec-TM. A similar decrease was observed after treatment of solubilized rabbit TM with chondroitinase ABC. As expected, chondroitinase ABC had no influence on the accelerating effect of low-Mr rec-TM. The free glycosaminoglycans obtained by alkaline treatment of TM or chondroitin sulphate A also accelerated the inactivation of scu-PA by thrombin, but about 1000-fold higher concentrations than with TM were needed to obtain the same acceleration. It is concluded that the major glycosaminoglycan of TM plays a pivotal role in the inactivation of scu-PA by the TM-thrombin complex, both in the formation and in the activity of the complex.

摘要

血栓调节蛋白(TM)是内皮细胞上的一种膜蛋白聚糖,以1:1复合物的形式与凝血酶结合,加速凝血酶对蛋白C的激活,促进抗凝血酶III对凝血酶的灭活,并抑制凝血酶的促凝血特性。血栓调节蛋白可使凝血酶对单链尿激酶型纤溶酶原激活剂(scu-PA)的灭活加速约70倍[德蒙克、格罗内维尔德和里肯(1991年)《临床研究杂志》88卷,第1680 - 1684页]。本研究探讨了血栓调节蛋白的O-连接糖胺聚糖部分在后者反应中的作用。在存在过量的完全糖基化可溶性重组人血栓调节蛋白突变体(高Mr重组TM)的情况下,0.11 nM凝血酶在37℃下45分钟内使4.4 nM scu-PA的50%失活。在存在缺乏糖胺聚糖的可溶性重组血栓调节蛋白突变体(低Mr重组TM)的情况下,需要1.9 nM凝血酶才能使50%的scu-PA失活,而在不存在血栓调节蛋白时则需要4.7 nM凝血酶。使用scu-PA失活测定法,发现高Mr重组TM的凝血酶 - 血栓调节蛋白相互作用的解离常数为0.4 nM,低Mr重组TM为14 nM。用软骨素酶ABC处理高Mr重组TM以消化糖胺聚糖,可使加速作用降低至低Mr重组TM的水平。在用软骨素酶ABC处理溶解的兔血栓调节蛋白后也观察到类似的降低。正如预期的那样,软骨素酶ABC对低Mr重组TM的加速作用没有影响。通过对血栓调节蛋白或硫酸软骨素A进行碱性处理获得的游离糖胺聚糖也能加速凝血酶对scu-PA的灭活,但需要比血栓调节蛋白高约一千倍的浓度才能获得相同的加速效果。得出的结论是,血栓调节蛋白的主要糖胺聚糖在血栓调节蛋白 - 凝血酶复合物对scu-PA的灭活中起关键作用,在复合物的形成和活性方面均如此。

相似文献

5
The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.
Biochim Biophys Acta. 2000 Sep 20;1497(3):351-8. doi: 10.1016/s0167-4889(00)00073-2.
7
The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: effect of thrombomodulin.
Blood Coagul Fibrinolysis. 1998 Jul;9(5):419-27. doi: 10.1097/00001721-199807000-00004.

本文引用的文献

5
Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.
Semin Thromb Hemost. 1987 Apr;13(2):152-9. doi: 10.1055/s-2007-1003486.
7
Functional domains of rabbit thrombomodulin.
Proc Natl Acad Sci U S A. 1986 Aug;83(16):5924-8. doi: 10.1073/pnas.83.16.5924.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验